These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1661 related articles for article (PubMed ID: 33705725)

  • 1. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy.
    Mehta P; Bunker CB; Ciurtin C; Porter JC; Chambers RC; Papdopoulou C; Garthwaite H; Hillman T; Heightman M; Howell KJ; Eleftheriou D; Denton CP
    Lancet Infect Dis; 2021 Jul; 21(7):912. PubMed ID: 33705725
    [No Abstract]   [Full Text] [Related]  

  • 2. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
    Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
    Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases.
    Romaní J; Baselga E; Mitjà O; Riera-Martí N; Garbayo P; Vicente A; Casals M; Fumadó V; Fortuny C; Calzado S
    Actas Dermosifiliogr (Engl Ed); 2020 Jun; 111(5):426-429. PubMed ID: 32402369
    [No Abstract]   [Full Text] [Related]  

  • 4. Chilblain-like acral dermatosis.
    Michelerio A; Vassallo C; Tomasini C
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1521-1523. PubMed ID: 34028985
    [No Abstract]   [Full Text] [Related]  

  • 5. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
    Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
    Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chilblain-like lesions in children following suspected COVID-19 infection.
    Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C
    Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of onychomadesis associated with chilblain-like lesions after COVID-19 infection.
    Colonna C; Giacalone S; Zussino M; Monzani NA; Cambiaghi S; Cavalli R
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e668-e669. PubMed ID: 35535454
    [No Abstract]   [Full Text] [Related]  

  • 9. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
    Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
    Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study.
    Robustelli Test E; Sena P; Locatelli AG; Carugno A; di Mercurio M; Moggio E; Gambini DM; Arosio MEG; Callegaro A; Morotti D; Gianatti A; Vezzoli P
    Pediatr Dermatol; 2022 Jan; 39(1):77-83. PubMed ID: 34989043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chilblain-like lesions with prominent bullae in a patient with COVID-19.
    Rubin A; Alamgir M; Rubin J; Rao BK
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?
    Signa S; Sementa AR; Coccia MC; Pastorino C; Viglizzo G; Viola S; Volpi S; Occella C; Bleidl D; Acquila M; Castagnola E; Ravelli A; Manunza F
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e475-e477. PubMed ID: 33871076
    [No Abstract]   [Full Text] [Related]  

  • 14. Coexisting Purpuric and Pseudo-Chilblain Lesions in COVID-19 Patients.
    Tammaro A; Alexander S; Adebanjo GAR; Parisella FR; Rello J; Ramirez-Estrada S
    Skinmed; 2022; 20(2):155-158. PubMed ID: 35532774
    [No Abstract]   [Full Text] [Related]  

  • 15. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
    Ramondetta A; Panzone M; Dapavo P; Ortoncelli M; Giura MT; Licciardello M; Rozzo G; Siliquini N; Fierro MT; Ribero S
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e440-e441. PubMed ID: 32421876
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions".
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Sep; 83(3):e233-e234. PubMed ID: 32446824
    [No Abstract]   [Full Text] [Related]  

  • 17. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
    Temiz SA; Abdelmaksoud A; Dursun R; Vestita M
    Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629
    [No Abstract]   [Full Text] [Related]  

  • 18. Chilblain-like lesions and COVID-19: second wave, second outbreak.
    Piccolo V; Bassi A; Russo T; Mazzatenta C; Baraldi M; Argenziano G; Neri I; Cutrone M
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):e316-e318. PubMed ID: 33545745
    [No Abstract]   [Full Text] [Related]  

  • 19. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
    Jindal R; Chauhan P; Goyal D; Shirazi N
    Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.